Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Gastrointestinal Infections specialty page provides gastrointestinal infection-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Exploring Microbiome Changes Associated with <i>C. diff</i> to Prevent or Reverse Colonization
A recent review article looks at literature exploring risk factors and C. diff epidemiology to inform future preventive strategies.
Stronger Hand Hygiene & Environmental Cleaning Best Combination for Reducing <i>C. diff</i>
An economic evaluation finds that a bundled approach of stronger hand hygiene and improved environmental cleaning proved to be the best combination for reducing C. diff.
High Dose Oral Vancomycin Optimal Treatment Regimen for <i>C. difficile</i>
A recent study finds high dose of oral vancomycin may be optimal treatment for C. difficile.
Eravacycline Proves Non-Inferior to Meropenem for the Treatment of cIAI in IGNITE4 Trial
Data from the IGNITE4 phase 3 trial supports the use of eravacycline for the treatment of complicated intra-abdominal infections (cIAI), including infections caused by pathogens resistant to other antibiotics.
Exploring the Best Treatment Option for Initial <em>C. diff</em> Infection In Pediatric Patients
Dr. Thomas Sandora shares recent data on screening for asymptomatic carriage of Clostridium difficile and provides insight into what the preferred first-line treatment for the infection in children.
Top Infectious Disease News of the Week—April 8, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Microbiota-Based Therapy Shows Promise for <i>C. difficile</i> Sufferers
One dose of microbiota-based therapy proved more effective than 2 at wiping out recurrent C. difficile infection.
Should Early FMT Be First-Line Treatment for Severe CDI?
Given the impressive efficacy of fecal microbiota transplantation (FMT) on decreasing recurrence of Clostridium difficile infection (CDI), the next logical step is seeing how it works for hospitalized patients with CDI.